✦ LIBER ✦

Target design for the LMJ

✍ Scribed by Pierre-André Holstein; M. André; M. Casanova; F. Chaland; C. Charpin; C. Cherfils; L. Divol; H. Dumont; D. Galmiche; J. Giorla; L. Hallo; S. Laffite; L. Lours; M.C. Monteil; D. Mourenas; F. Poggi; Y. Saillard; G. Schurtz; M. Valadon; D. Vanderhaegen; F. Wagon

Book ID: 108489655
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 501 KB
Volume: 1
Category: Article
ISSN: 1296-2147
DOI: 10.1016/s1296-2147(00)01096-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial Designs for Targeted Therapies

✍ Simon G. Thompson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Target field design for MAMBA step field

Target field design for MAMBA step fields

✍ Lee, K.J. ;Paley, M.N.J. ;Barber, D.C. ;Wilkinson, I.D. ;Griffiths, P.D. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

Optimal target selection for unbalanced

Optimal target selection for unbalanced tolerance design

✍ M.-H.Caleb Li 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 313 KB

On waveform design for optimal target di

On waveform design for optimal target discrimination

✍ Lloyd S. Riggs; Michael A. Richards; Thomas H. Shumpert; C. Ray Smith 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Probability theory is applied to the problem of radar target discrimination. The theory is used to construct an excitation waveform (an enhanced discrimination pulse) which maximizes the posterior odds in favor of one target over the other. It is shown that the enhanced discrimination pulse has its

Design considerations for tumour-targete

Design considerations for tumour-targeted nanoparticles

✍ Choi, Hak Soo; Liu, Wenhao; Liu, Fangbing; Nasr, Khaled; Misra, Preeti; Bawendi, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 579 KB

Design maps for nanoparticles targeting

Design maps for nanoparticles targeting the diseased microvasculature

✍ Paolo Decuzzi; Mauro Ferrari 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 440 KB

Systemically administered ligand-coated nanoparticles have been proved to recognize biological targets in-vivo. This can provide breakthrough solutions for the early detection, imaging and cure of diseases. In cardiovascular applications, nanoparticles have been targeted directly to the diseased vas